The test’s ability to distinguish ALS from similar conditions is particularly noteworthy. It could help physicians differentiate between ALS and conditions that mimic its symptoms, such as primary ...
According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...
Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback